Key facts
- NanoImaging Services’s last known valuation is $62.2M (Jan 2025).
- It has raised $19.7M across 1 recorded rounds; the latest was Early Stage VC ($12.2M) in Sep 2024.
- Notable investors include National Institutes of Health, Ampersand Capital Partners, Field Electron and Ion.
- NanoImaging Services has filed 3 Form Ds with the SEC since 2023, most recently Jan 2025 ($12.2M sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for NanoImaging Services
Funding rounds
1 roundsAbout NanoImaging Services
Provider of transmission electron microscopy imaging services intended to support imaging, analysis, and documentation requirements. The company's services focus on the characterization of biological molecules used in biopharmaceuticals, including vaccines, antibodies, cytokines, hormones, and gene therapies, enabling pharmaceutical, biotechnology, and nanotechnology companies to directly visualize samples preserved in their native hydrated state.
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2007
- Employees
- 52
- Website
- nanoimagingservices.com/
- Ownership
- Privately Held (backing)
NanoImaging Services doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in NanoImaging Services shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on NanoImaging Services in its N-PORT filings yet. We sweep new filings monthly.